DE69330639T2 - Methotrexat-derivate - Google Patents

Methotrexat-derivate

Info

Publication number
DE69330639T2
DE69330639T2 DE69330639T DE69330639T DE69330639T2 DE 69330639 T2 DE69330639 T2 DE 69330639T2 DE 69330639 T DE69330639 T DE 69330639T DE 69330639 T DE69330639 T DE 69330639T DE 69330639 T2 DE69330639 T2 DE 69330639T2
Authority
DE
Germany
Prior art keywords
general formula
compound
carbon atoms
lower alkyl
alkyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69330639T
Other languages
German (de)
English (en)
Other versions
DE69330639D1 (de
Inventor
Nobuaki Kato
Toshio Kuroki
Noriaki Maruyama
Hiroharu Matsuoka
Kazuya Nakagomi
Hiroshi Suzuki
Keiichiro Tsuji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE69330639D1 publication Critical patent/DE69330639D1/de
Application granted granted Critical
Publication of DE69330639T2 publication Critical patent/DE69330639T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69330639T 1992-01-27 1993-01-27 Methotrexat-derivate Expired - Fee Related DE69330639T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP5305192 1992-01-27
JP7510692 1992-02-13
JP10832092 1992-03-16
JP11512692 1992-03-24
PCT/JP1993/000096 WO1993015077A1 (fr) 1992-01-27 1993-01-27 Derive de methotrexate

Publications (2)

Publication Number Publication Date
DE69330639D1 DE69330639D1 (de) 2001-09-27
DE69330639T2 true DE69330639T2 (de) 2002-07-04

Family

ID=27462860

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69330639T Expired - Fee Related DE69330639T2 (de) 1992-01-27 1993-01-27 Methotrexat-derivate

Country Status (10)

Country Link
US (2) US6559149B1 (enExample)
EP (1) EP0632038B1 (enExample)
KR (1) KR100248324B1 (enExample)
AT (1) ATE204576T1 (enExample)
AU (1) AU3367693A (enExample)
CA (1) CA2128205C (enExample)
DE (1) DE69330639T2 (enExample)
ES (1) ES2161713T3 (enExample)
TW (1) TW223637B (enExample)
WO (1) WO1993015077A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69330639T2 (de) * 1992-01-27 2002-07-04 Chugai Seiyaku K.K., Tokio/Tokyo Methotrexat-derivate
CA2152485A1 (en) * 1992-12-25 1994-07-07 Nobuhiro Ohi Methotrexate derivative
KR100400509B1 (ko) * 1995-03-27 2004-04-03 쥬가이 세이야쿠 가부시키가이샤 메토트렉세이트유도체를함유하는약제
US7276506B2 (en) * 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
CA2408913A1 (en) * 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Melanin-concentrating hormone antagonist
US20070032477A1 (en) * 2003-10-17 2007-02-08 Waer Mark J A Pteridine derivatives useful for making pharmaceutical compositions
US20060039985A1 (en) * 2004-04-27 2006-02-23 Bennett David B Methotrexate compositions
US7601834B2 (en) * 2005-02-22 2009-10-13 Savvipharm Inc Compositions and methods of reducing side effects and toxicity of methotrexate when given as orotate derivatives
US20070123478A1 (en) 2005-11-28 2007-05-31 Rowe Vernon D Compositions useful for reducing nephrotoxicity and methods of use thereof
WO2007098089A2 (en) * 2006-02-17 2007-08-30 Novacea, Inc. Treatment of hyperproliferative diseases with methotrexate n-oxide and analogs
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
WO2008009079A2 (en) * 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
CN101646670A (zh) 2007-04-11 2010-02-10 默克阿泼洛发股份公司 18f-标记的叶酸酯
EP3173063B1 (en) 2008-11-19 2019-12-25 Pola Chemical Industries Inc. Anti-wrinkle agents
SMT201800023T1 (it) 2015-03-04 2018-03-08 Gilead Sciences Inc Composti 4,6-diamminopirido[3,2-d]pirimidinici modulanti i recettori di tipo toll
ES2826748T3 (es) 2016-09-02 2021-05-19 Gilead Sciences Inc Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
PT3507276T (pt) 2016-09-02 2022-01-11 Gilead Sciences Inc Compostos moduladores do recetor de tipo toll
TWI751517B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI751516B (zh) 2019-04-17 2022-01-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TWI879779B (zh) 2019-06-28 2025-04-11 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI812775L (fi) * 1980-09-12 1982-03-13 Farmos Oy Foerfarande foer framstaellning av n-/4-/(2,4-diamino-6-pteridinyl)-metyl/metylamino/benzoyl/glutaminsyra och derivat daerav
US4490529A (en) * 1983-09-06 1984-12-25 Dana-Farber Cancer Institute, Inc. Cysteic acid and homocysteic acid analogues of methotrexate and aminopterin
AU8333291A (en) * 1990-08-14 1992-03-17 Chugai Seiyaku Kabushiki Kaisha Novel methotrexate derivative
JP3124592B2 (ja) * 1990-08-14 2001-01-15 中外製薬株式会社 新規メトトレキセート誘導体
DE69330639T2 (de) * 1992-01-27 2002-07-04 Chugai Seiyaku K.K., Tokio/Tokyo Methotrexat-derivate
JP3207285B2 (ja) * 1992-01-27 2001-09-10 中外製薬株式会社 新規メトトレキセート誘導体
JP3274532B2 (ja) * 1992-03-24 2002-04-15 中外製薬株式会社 抗リウマチ剤

Also Published As

Publication number Publication date
CA2128205A1 (en) 1993-08-05
CA2128205C (en) 2004-03-30
US6559149B1 (en) 2003-05-06
TW223637B (enExample) 1994-05-11
DE69330639D1 (de) 2001-09-27
US20030171376A1 (en) 2003-09-11
EP0632038B1 (en) 2001-08-22
ES2161713T3 (es) 2001-12-16
EP0632038A1 (en) 1995-01-04
ATE204576T1 (de) 2001-09-15
KR100248324B1 (ko) 2000-04-01
EP0632038A4 (en) 1995-02-22
AU3367693A (en) 1993-09-01
WO1993015077A1 (fr) 1993-08-05

Similar Documents

Publication Publication Date Title
DE69330639T2 (de) Methotrexat-derivate
DE69006482T2 (de) Anti-krebs-verbindungen.
DE69533277T2 (de) Dc-89 derivat
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
DE69202243T2 (de) 2,4-Diaminochinazolin-Derivate, um die Antitumorwirkung zu erhöhen.
EP0281902B1 (de) Bis-naphthalimide, ihre Herstellung und Verwendung
DE69625506T2 (de) Schwefelsubstituierte peptide als inhibitoren für metalloproteinasen und der tnf-freisetzung
DE69330072T2 (de) Imidazolderivate mit Anti-HIV-Aktivität
DE3783176T2 (de) Bis-dioxopiperazin-abkoemmlinge.
DE3044740A1 (de) Nucleosidderivate, ihre herstellung und pharmazeutische mittel
DE68910211T2 (de) Estramustin-ester.
DE2749988A1 (de) N-substituierte imidazolcarboxamide, verfahren zu deren herstellung und dieselben enthaltendes mittel
DE69320875T2 (de) Fumarsäuresalze von Chinolinderivaten zur Aufhebung von vielfacher Drogenresistenz in der Krebsbehandlung
DE69318046T2 (de) Antikrebsbenzaldehydverbindungen
DE69326479T2 (de) Methotrexat-derivate
EP0409125B1 (de) Salze von N5, N10 - Methylen-5,6,7,8-tetrahydrofolsäure
DE1593728C3 (de) Substituierte Amidine und Verfahren zu ihrer Herstellung
DE3217769A1 (de) Mitomycon-analoge verbindungen
EP0338308A2 (de) Substituierte N-Glycosylamide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE3879378T2 (de) Amid-verbindungen.
DE69207182T2 (de) Antitumor anthracenderivate
DE69510527T2 (de) Iodo-derivate ihre herstellung und verwendung als kontrastmittel für röntgen-radiologie
DE3686266T2 (de) Neue 5-fluoruridin-verbindungen und deren herstellung.
DE2815442A1 (de) Rasch wirksame diuretika
DE3531453A1 (de) Substituierte 7-oxomitosan-verbindungen, verfahren zu deren herstellung und diese verbindungen enthaltende, pharmazeutische mittel

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee